(Q48408726)

English

Study of the cerebrospinal fluid penetrability of ofloxacin

scientific article published in January 1986

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/3469155

Study of the cerebrospinal fluid penetrability of ofloxacin (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/3469155

cerebrospinal fluid

0 references

author name string

G Stübner

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/3469155

W Weinrich

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/3469155

U Brands

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/3469155

publication date

1 January 1986

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/3469155

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/3469155

14 Suppl 4

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/3469155

S250-3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/3469155

The discrimination between different blood-CSF barrier dysfunctions and inflammatory reactions of the CNS by a recent evaluation graph for the protein profile of cerebrospinal fluid

1 reference

https://pubmed.ncbi.nlm.nih.gov/3469155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the antibacterial in vitro and in vivo activity of ofloxacin (HOE 280 DL 8280) and nalidixic acid analogues

1 reference

https://pubmed.ncbi.nlm.nih.gov/3469155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-vitro activity of enoxacin, ofloxacin, norfloxacin and nalidixic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/3469155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01661285

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/3469155

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/3469155

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48408726&oldid=2209437157"